CLINICAL_TRIALS
trial_result
· 2024-04-02
Clinical Trial Update: Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension [Phase 4]
Summary
Phase 4 trial assessing outpatient vasodilator therapy with iloprost for pulmonary hypertension was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Pulmonary Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2024-04-02